Should you sell your shares if they report badly?

Earnings season is underway, what should you do when your shares report?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earnings season is now well underway and it's a great chance to have a look at how our shares have done over the past year.

Some of them may report profit figures reflecting what the market expected, but there may be others that don't do so well.

What should you do if your shares report figures that are below expectations?

Don't panic, that is the first thing to make sure of. There are very few businesses in the world that report growth every single year and half-year.

With a cool, logical frame of mind you need to analyse why the business was below expectations. Were you and the market expecting too much growth from this report?

In most scenarios where the share price drops after a report I think investors have to consider if it's a long-term issue or a short-term issue. Ramsay Health Care Limited (ASX: RHC) and Healthscope Ltd (ASX: HSO) could report one bad year but the ageing demographics of Australia should still heavily boost them in the long-term.

However, Cabcharge Australia Limited (ASX: CAB) reporting lower revenue could be something it never recovers from.

If Wesfarmers Ltd (ASX: WES) reports lower profit and profit margins due to competitors it's worth thinking about if those competitors are ever going to go away.

Perhaps it's an opportunity

If one of your favourites reports underwhelming numbers but the long-term investment thesis is intact then that could actually create an opportunity to buy more shares if the price drops temporarily.

I don't want Challenger Ltd (ASX: CGF), Ramsay or National Veterinary Care Ltd (ASX: NVL) to report below expectations but I'll be ready to buy shares if the price falls.

Foolish takeaway

Never forget that investing is a long-term activity that rewards patient shareholders. You just have to make sure you're invested in shares that will grow over the long-term.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited, HEALTHSCPE DEF SET, NATVETCARE FPO, and Ramsay Health Care Limited. The Motley Fool Australia owns shares of Challenger Limited and Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »